Microneedle Patch for Peanut Allergies Begins Clinical Trials
A phase 1 study is testing the safety of a microneedle device designed to deliver peanut protein through the skin for desensitization.
A phase 1 study is testing the safety of a microneedle device designed to deliver peanut protein through the skin for desensitization.
HHS secretary Robert F Kennedy, Jr signed determinations to end COVID-19 emergency use authorizations for drugs, biological products, and medical devices because the emergency circumstances no longer exist.
For patients in the pediatric ICU, pulse oximetry and waveform capnography are valuable tools to monitor the effectiveness of respiratory support and to inform treatment decisions.
The software-as-a-medical-device allows for contactless measurement of respiratory and pulse rates using only a standard smartphone camera.
Phase 3 trial results indicate a new antifungal medication olorofim is as effective as current standard treatments for invasive aspergillosis with fewer side effects.
The MATCH 2 study reported a 96.7% overall diagnostic yield for peripheral lung nodules when using robotic-assisted bronchoscopy (RAB) with integrated imaging.
Remote monitoring did not increase the time spent at home after discharge among patients hospitalized with sepsis or lower respiratory tract infection, according to results from a randomized clinical trial of 1,286 adults.